Pharmacokinetics and Safety of Oliceridine Fumarate Injection in Chinese Patients with Chronic Non-Cancer Pain: A Phase I, Single-Ascending-Dose, Open-Label Clinical Trial

Pharmacokinetics and Safety of Oliceridine Fumarate Injection in Chinese Patients with Chronic Non-Cancer Pain: A Phase I, Single-Ascending-Dose, Open-Label Clinical Trial

Yuncheng Ni,1,* Ranglang Huang,2,* Shuang Yang,3 Xiao Yan Yang,3 Shan Zeng,3 An Yao,3 Jie Huang,3 Guoping Yang3,4 1Department of Pain, The Third Xiangya Hospital and Institute of Pain Medicine, Central South University, Changsha, Hunan, 410013, People’s Republic of China; 2Department...

Full description

Bibliographic Details
Main Authors: Ni Y, Huang R, Yang S, Yang XY, Zeng S, Yao A, Huang J, Yang G
Format: Article
Language:English
Published: Dove Medical Press 2024-07-01
Series:Drug Design, Development and Therapy
Subjects:
pharmacokinetics
oliceridine
chronic pain
g-protein-biased ligand
phase i trial
Online Access:https://www.dovepress.com/pharmacokinetics-and-safety-of-oliceridine-fumarate-injection-in-chine-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/pharmacokinetics-and-safety-of-oliceridine-fumarate-injection-in-chine-peer-reviewed-fulltext-article-DDDT

Similar Items